Cudarolimab Antibody
Cudarolimab (IBI-101) is a fully human monoclonal antibody targeting the OX40 immune checkpoint. It is designed to activate T-cells and exhibits anti-tumor activity, making it a candidate for cancer immunotherapy research. Its mechanism and efficacy have been investigated in preclinical in vitro and in vivo studies across various cancer models.
Product Specifications
Product Name Alternative
IBI101, IBI-101, Inflammationrelated, Inflammation related, Immunologyrelated, Immunology related, OX40
Target
Immunology/Inflammation related, OX Receptor
Clonality
Monoclonal
Conjugation
Unconjugated
Field of Research
Immunology & Inflammation, Neuroscience, Pharmacology & Drug Discovery
Concentration
5.66 mg/mL
Purity
97.50% (May vary between batches)
Molecular Weight
145.67 kDa
Storage Conditions
Maintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.
Notes
For research use only.
Available Sizes
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
IFIH1 (Interferon-induced Helicase C Domain-containing Protein 1, Interferon Induced with Helicase C Domain 1)
Rabbit Abdominal Aortic Adventitial Fibroblast Medium
